As part of the London Proteomics Discussion Group webinar series: "SARS-CoV-2: What role can proteomics play?" Dr Münch presented his work on changes in response to SARS-CoV-2 infection, highlighting potential therapies. This was presented on 3rd Aptil 2020 to a global audience.

Register for part two of the series here.